Glaucoma Sales update
Filed with ASX · · 3 pages · English
Story so far
Earlier from Nova Eye Medical
- iTrack Advance Commercial Roll-Out Commenced
- AlphaRet Investor Presentation
- 2RT Pivotal Study and Regulatory Pathway
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
- Investor presentation Half Year Results 31 December 2021
Later from Nova Eye Medical
- Appendix 4E and Annual Report FY22
- Investor Presentation FY22
- Results Announcement FY22
- Clarification Glaucoma Surgical Devices Sales Update
- AGM presentation 2022
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical